(((9H-Fluoren-9-yl)methoxy)carbonyl)-D-tyrosine, 95%, 10g

1-isobutyl-3-methyl-1H-pyrazol-5-amine, 95.0%, 5g

4-Bromo-3,5-dimethyl-benzonitrile, 99.00%, 50g

1-[2-(Phenoxy)-ethyl]piperazine, 95.0%, 2.5g

Monomethacryloxypropylterminated polydimethylsiloxane - asymmetric cSt 150-200 inhibited with BHT, 100g

3-Methyl-5-(piperidin-4-yl)isoxazole, 95.0%, 250mg

2-Propanol

Methyl 2-bromopyrimidine-5-carboxylate, 95+%, 100mg

Ethyl 5-amino-1,2,3-thiadiazole-4-carboxylate, 98%, 250mg

(R)-1-BOC-3-METHYL-[1,4]DIAZEPANE, 95.0%, 5g

3-Fluoro-5-nitropyridin-2-ol, 95.0%, 5g

1-(2,4-DIHYDROXY-PHENYL)2 (4-HYDROXY-PHENYL)-ETHANONE, 98.0%, 5g

((3S,5R)-5-((1H-1,2,4-Triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methyl 4-methylbenzenesulfonate, 97%, 1g